Puerarin induces apoptosis in prostate cancer cells via inactivation of the Keap1/Nrf2/ARE signaling pathway

References

• Chen W, Zheng R, Zeng H, et al. Annual report on status of cancer in China, 2011. Chin J Cancer Res. 2015;27(1):2–12.
   PubMed Web of Science ®Google Scholar
• Cai F, Zhang Y, Li J, et al. Isorhamnetin inhibited the proliferation and metastasis of androgen-independent prostate cancer cells by targeting the mitochondrion-dependent intrinsic apoptotic and PI3K/Akt/mTOR pathway. Biosci Rep. 2020;40(3):BSR20192826.
   PubMedGoogle Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Zhang S, et al. Cancer incidence and mortality in China, 2013. Cancer Lett. 2017;401:63–71.
   PubMed Web of Science ®Google Scholar
• Yang B, Zhang D, Qian J, et al. Chelerythrine suppresses proliferation and metastasis of human prostate cancer cells via modulating MMP/TIMP/NF-κB system. Mol Cell Biochem. 2020; 10.1007/s11010-020-03845-0 (1–2): 199–208. DOI: 10.1007/s11010-020-03845-0.
   Web of Science ®Google Scholar
• Uemura H, Ishiguro H, Nakaigawa N, et al. Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor. Mol Cancer Ther. 2003;2(11):1139–1147.
   PubMed Web of Science ®Google Scholar
• Li J, Luo J, Gu D, et al. Adenovirus-mediated Angiotensin II type 2 receptor overexpression inhibits tumor growth of prostate cancer in vivo. J Cancer. 2016;7(2):184–191.
   PubMed Web of Science ®Google Scholar
• Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer. 2001;1(1):34–45.
   PubMed Web of Science ®Google Scholar
• Petrylak DP. The current role of chemotherapy in metastatic hormone-refractory prostate cancer. Urology. 2005;65(5):3–8.
   PubMedGoogle Scholar
• Xu YM, Wijeratne EMK, Babyak AL, et al. Withanolides from Aeroponically grown physalis peruviana and their selective cytotoxicity to prostate cancer and renal carcinoma cells. J Nat Prod. 2017;80(7):1981–1991.
   PubMed Web of Science ®Google Scholar
• Zhang X, Chen LX, Ouyang L, et al. Plant natural compounds: targeting pathways of autophagy as anti-cancer therapeutic agents. Cell Prolif. 2012;45(5):466–476.
   PubMed Web of Science ®Google Scholar
• Ye G, Kan S, Chen J, et al. Puerarin in inducing apoptosis of bladder cancer cells through inhibiting SIRT1/p53 pathway. Oncol Lett. 2019;17(1):195–200.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhao W, Wang W, et al. Puerarin suppresses LPSinduced breast cancer cell migration, invasion and adhesion by blockage NF-κB and Erk pathway. Biomed Pharmacother. 2017;92:429–436.
   PubMed Web of Science ®Google Scholar
• Zhang XL, Wang BB, Mo JS. Puerarin 6″-O-xyloside possesses significant antitumor activities on colon cancer through inducing apoptosis. Oncol Lett. 2018;16(5):5557–5564.
   PubMed Web of Science ®Google Scholar
• Huang P, Du SX. Puerarin enhances the anti-tumor effect of cisplatin on drug-resistant A549 cancer in vivo and in vitro through activation of the Wnt signaling pathway. Cancer Manag Res. 2020;12:6279–6289.
   PubMed Web of Science ®Google Scholar
• Jia L, Hu Y, Yang G, et al. Puerarin suppresses cell growth and migration in HPV-positive cervical cancer cells by inhibiting the PI3K/mTOR signaling pathway. Exp Ther Med. 2019;18(1):543–549.
   PubMed Web of Science ®Google Scholar
• Wang J, Yang ZR, Guo XF, et al. Synergistic effects of puerarin combined with 5-fluorouracil on esophageal cancer. Mol Med Rep. 2014;10(5):2535–2541.
   PubMed Web of Science ®Google Scholar
• Jiang K, Chen H, Tang K, et al. Puerarin inhibits bladder cancer cell proliferation through the mTOR/p70S6K signaling pathway. Oncol Lett. 2018;15(1):167–174.
   PubMed Web of Science ®Google Scholar
• Guo XF, Yang ZR, Wang J, et al. Synergistic antitumor effect of puerarin combined with 5-fluorouracil on gastric carcinoma. Mol Med Rep. 2015;11(4):2562–2568.
   PubMed Web of Science ®Google Scholar
• Yu Z, Li W. Induction of apoptosis by puerarin in colon cancer HT-29 cells. Cancer Lett. 2006;238(1):53–60.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 2016;79(3):629–661.
   PubMed Web of Science ®Google Scholar
• Arias-González I, García-Carrancá AM, Cornejo-Garrido J, et al. Cytotoxic effect of Kalanchoe flammea and induction of intrinsic mitochondrial apoptotic signaling in prostate cancer cells. J Ethnopharmacol. 2018;222:133–147.
   PubMed Web of Science ®Google Scholar
• Singh RP, Agarwal R. Mechanisms of action of novel agents for prostate cancer chemoprevention. Endocr Relat Cancer. 2006;13(3):751–778.
   PubMed Web of Science ®Google Scholar
• Shen W, Guan Y, Wang J, et al. A polysaccharide from pumpkin induces apoptosis of HepG2 cells by activation of mitochondrial pathway. Tumour Biol. 2016;37(4):5239–5245.
   PubMedGoogle Scholar
• Zeng CC, Lai SH, Yao JH, et al. The induction of apoptosis in HepG-2 cells by ruthenium(II) complexes through an intrinsic ROS-mediated mitochondrial dysfunction pathway. Eur J Med Chem. 2016;122:118–126.
   PubMed Web of Science ®Google Scholar
• Wu P, Meng X, Zheng H, et al. Kaempferol attenuates ROS-induced hemolysis and the molecular mechanism of its induction of Apoptosis on bladder cancer. Molecules. 2018;23(10):2592.
   PubMed Web of Science ®Google Scholar
• Wongtongtair S, Chanvorachote P, Hutamekalin P, et al. Barakol-induced apoptosis in P19 cells through generation of reactive oxygen species and activation of caspase-9. J Ethnopharmacol. 2011;137(2):971–978.
   PubMed Web of Science ®Google Scholar
• Moharram S, Zhou A, Wiebe LI, et al. Design and synthesis of 3ʹ- and 5ʹ-O-(3-benzenesulfonylfuroxan-4-yl)-2ʹ-deoxyuridines: biological evaluation as hybrid nitric oxide donor-nucleoside anticancer agents. J Med Chem. 2004;47(7):1840–1846.
   PubMed Web of Science ®Google Scholar
• Fukuzawa K, Kogure K, Morita M, et al. Enhancement of nitric oxide and superoxide generations by alpha-tocopheryl succinate and its apoptotic and anticancer effects. Biochemistry (Mosc). 2004;69(1):50–57.
   PubMed Web of Science ®Google Scholar
• Li P, Li Z. Neuroprotective effect of paeoniflorin on H2O2-induced apoptosis in PC12 cells by modulation of reactive oxygen species and the inflammatory response. Exp Ther Med. 2015;9(5):1768–1772.
   PubMed Web of Science ®Google Scholar
• Jeong WS, Jun M, Kong AN. Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxid Redox Signal. 2006;8(1–2):99–106.
   PubMed Web of Science ®Google Scholar
• Kansanen E, Kuosmanen SM, Leinonen H, et al. The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biol. 2013;1(1):45–49.
   PubMed Web of Science ®Google Scholar
• O’Connell MA, Hayes JD. The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic. Biochem Soc Trans. 2015;43(4):687–689.
   PubMedGoogle Scholar
• Li AL, Shen T, Wang T, et al. Novel diterpenoid-type activators of the Keap1/Nrf2/ARE signaling pathway and their regulation of redox homeostasis. Free Radic Biol Med. 2019;141:21–33.
   PubMed Web of Science ®Google Scholar
• Chen M, Xi Y, Chen K, et al. Upregulation Sestrin2 protects against hydrogen peroxide-induced oxidative damage bovine mammary epithelial cells via a Keap1-Nrf2/ARE pathway. J Cell Physiol.
   Web of Science ®Google Scholar
• Liby KT, Sporn MB. Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease. Pharmacol Rev. 2012;64(4):972–1003.
   PubMed Web of Science ®Google Scholar
• Hassanein EHM, Sayed AM, Hussein OE, et al. Coumarins as modulators of the Keap1/Nrf2/ARE signaling pathway. Oxid Med Cell Longev. 2020;2020:1675957.
   PubMedGoogle Scholar
• Zhang DD. The Nrf2-Keap1-ARE signaling pathway: the regulation and dual function of Nrf2 in cancer. Antioxid Redox Signal. 2010;13(11):1623–1626.
   PubMed Web of Science ®Google Scholar
• Satoh H, Moriguchi T, Taguchi K, et al. Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung. Carcinogenesis. 2010;31(10):1833–1843.
   PubMed Web of Science ®Google Scholar
• Hao B, Miao Z, Yuan Y. Clinical significance of Nrf2 expression in benign prostatic hyperplasia and prostate cancer tissues. Int J Clin Exp Pathol. 2016;9(1):118–123.
   Web of Science ®Google Scholar
• Bellezza I, Scarpelli P, Pizzo SV, et al. ROS-independent Nrf2 activation in prostate cancer. Oncotarget. 2017;8(40):67506–67518.
   PubMedGoogle Scholar
• Chen JY, Wang FB, Xu H, et al. High glucose promotes prostate cancer cells apoptosis via Nrf2/ARE signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23(3 Suppl):192–200.
   PubMedGoogle Scholar